Q3 Impella sales help Abiomed close in on the black

February 4, 2010 by MassDevice staff

Third-quarter sales of its Impella heart pump helped Abiomed Inc. slash its net losses again, as total Q3 sales rise 32 percent.

ABMD logo

Abiomed Inc. (NSDQ:ABMD) continued its ride toward profitability on the back of its Impella cardiac assist device, paring its third-quarter net loss by more than 40 percent and posting a 32 percent increase in total sales.

The Danvers, Mass.-based company reported net losses of $4.6 million, or 12 cents per share, on revenues of $22.8 million during the three months ended Dec. 31, 2009, compared with net losses of $7.7 million, or 21 cents per share, on revenues of $17.3 million during Q3 2009.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp